Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testingC Lerman, C Hughes, S J Lemon, et al.
British Journal of Cancer|February 25, 2012
HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situE Rakovitch, S Nofech-Mozes, W Hanna, et al.
American Journal of Obstetrics and Gynecology|April 16, 1999
Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screeningB Y Karlan, R L Baldwin, E Lopez-Luevanos, et al.
Human Molecular Genetics|August 1, 1993
Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locusM Sanson, C Marineau, C Desmaze, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 1, 2011
Expression of HER2neu in ductal carcinoma in situ is associated with local recurrenceK Han, S Nofech-Mozes, S Narod, et al.
The Journal of Urology|August 1, 1995
Family history and the risk of prostatic carcinoma in a high risk group of urological patientsA G Aprikian, M Bazinet, M Plante, et al.
Pediatrie|January 1, 1990
[Neuroblastoma in the Rhone-Alpes area: epidemiologic data]P Renaux, P Mathieu, F Chauvin, et al.
Pageof 5